Course of platelet counts in cirrhotic patients after implantation of a transjugular intrahepatic portosystemic shunt - A prospective, controlled study

Journal of Hepatology

Volumn 30, Issue 2, 1999, Pages 254-259

  Gschwantler, Michael ^a   Vavrik, Joachim ^b   Gebauer, Axel ^b   Kriwanek, Stephan ^b   Schrutka Kölbl, Christiane ^a   Fleischer, Johannes ^a   Madani, Babak ^b   Brownstone, Eva ^a   Tscholakoff, Dimiter ^b   Weiss, Werner ^a  

^a V Department of Internal Medicine   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Hypersplenism; Portal hypertension; Thrombocytopenia; Transjugular intrahepatic portosystemic shunt (TIPS)

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; IMPLANTATION; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PORTAL HYPERTENSION; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

EID: 0032960950     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(99)80071-3     Document Type: Article

References (31)

1. Lechner K, Niessner H, Thaler E. Coagulation abnormalities in liver disease. Semin Thromb Hemost. 4:1977;40-56.
2. Aster RH. Pooling of platelets in the spleen: role in the pathogenesis of "hypersplenic" thrombocytopenia. J Clin Invest. 45:1966;645-647.
3. Toghill PJ, Green S. Platelet dynamics in chronic liver disease using the 111-indium oxide label. Gut. 24:1983;49-52.
4. Puttini M, Marni A, Montes F, Belli L. Effect of portasystemic shunt on hypersplenism: clinical study in 129 patients with cirrhosis. Am Surg. 45:1979;444-448.
5. Soper NJ, Rikkers LF. Effect of operations for variceal hemorrhage on hypersplenism. Am J Surg. 144:1982;700-703.
6. Ferrara J, Ellison EC, Martin EW Jr, Cooperman M. Correction of hypersplenism following distal splenorenal shunt. Surgery 1979; 86: 570-573.
7. Marni A, Trojsi C, Belli L. Distal splenorenal shunt. Hemodynamic advantage over total shunt and influence on clinical status, hepatic function and hypersplenism. Am J Surg. 142:1981;372-376.
8. Hutson DG, Zeppa R, Levi JU, Schiff ER, Livingstone AS, Fink P. The effect of the distal splenorenal shunt on hypersplenism. Ann Surg. 185:1977;605-612.
9. McAllister E, Goode S, Cordista AG, Rosemurgy A. Partial portal decompression alleviates thrombocytopenia of portal hypertension. Am Surg. 61:1995;129-131.
10. Luzzatto G, Fabris F, Gerunda GE, Maffei-Faccioli A, Nacarato R, Girolami A. Thrombocytopenia in liver cirrhosis complicated by variceal hemorrhage: lack of increase in platelet count after splenorenal distal shunt. Folia Haematol Int Mag Klin Morphol Blutforsch. 114:1987;145-152.
11. Mutchnick MG, Lerner E, Conn HO. Effect of portacaval anastomosis on hypersplenism. Dig Dis Sci. 25:1980;929-938.
12. Lawrence SP, Lezotte DC, Durhan JD, Kumpe DA, Everson GT, Bilir BM. Course of thrombocytopenia of chronic liver disease after transjugular intrahepatic portosystemic shunts (TIPS). A retrospective analysis. Dig Dis Sci. 40:1995;1575-1580.
13. Alvarez OA, Lopera GA, Patel V, Encarnacion CE, Palmaz JC, Lee M. Improvement of thrombocytopenia after transjugular intrahepatic portosystemic shunt placement in cirrhotic patients. Am J Gastroenterol. 91:1996;134-137.
14. Pursnani KG, Sillin LF, Kaplan DS. Effect of transjugular intrahepatic portosystemic shunt on secondary hypersplenism. Am J Surg. 173:1997;169-173.
15. Sanyal AJ, Freedman AM, Purdum PP, Shiffman ML, Luketic VA. The hematologic consequences of transjugular intrahepatic portosystemic shunts. Hepatology. 23:1996;32-39.
16. La Berge JM, Ring EJ, Gordon RL, Lake JR, Doherty MM, Somberg KA, et al. Creation of transjugular intrahepatic portosystemic shunts with the Wallstent endoprothesis: results in 100 patients. Radiology. 187:1993;413-420.
17. Jalan R, Redhead DN, Allan PL, Hayes PC. Prospective evaluation of haematological alterations following the transjugular intrahepatic portosystemic stent-shunt (TIPSS). Eur J Gastroenterol Hepatol. 8:1996;381-385.
18. Rössle M, Haag K, Ochs A, Sellinger M, Nöldge G, Perarnau JM, et al. The transjugular intrahepatic portosystemic stentshunt procedure for variceal bleeding. N Engl J Med. 330:1994;165-171.
19. Ochs A, Rössle M, Haag K, Hauenstein KH, Deibert P, Sicgerstetter V, et al. The transjugular intrahepatic portosystemic stentshunt procedure for refractory ascites. N Engl J Med. 332:1995;1192-1197.
20. Gschwantler M, Gebauer A, Rohrmoser M, Schrutka-Kölbl C, Vavrik J, Brownstone E, et al. Clinical outcome two years after implantation of a transjugular intrahepatic portosystemic shunt for recurrent variceal bleeding. Eur J Gastroenterol Hepatol. 9:1997;15-20.
21. Gschwantler M, Gebauer A, Vavrik J, Madani B, Rohrmoser M, Schrutka-Kölbl C, et al. Acute and chronic complications after implantation of a transjugular intrahepatic portosystemic shunt. Z Gastroenterol. 35:1997;999-1005.
22. Cabrera J, Maynar M, Granados R, Gorriz E, Reyes R, Pulido-Duque JM, et al. Transjugular intrahepatic portosystemic shunt versus sclerotherapy in the elective treatment of variceal hemorrhage. Gastroenterology. 110:1996;832-839.
23. Sauer P, Theilmann L, Stremmel W, Benz C, Richter GM, Stiehl A. Transjugular intrahepatic portosystemic stent shunt versus sclerotherapy plus propranolol for variceal rebleeding. Gastroenterology. 113:1997;1623-1631.
24. Cello JP, Ring EJ, Olcott EW, Koeh J, Gordon R, Sandhu J, et al. Endoscopic sclerotherapy compared with percutaneous transjugular intrahepatic portosystemic shunt after initial sclerotherapy in patients with acute variceal hemorrhage. A randomized, controlled trial. Ann Intern Med. 126:1997;858-865.
25. Sanyal AJ, Freedman AM, Luketic VA, Purdum PP-3rd, Shiffman ML, Cole PE, et al. Transjugular intrahepatic portosystemic shunts compared with endoscopic sclerotherapy for the prevention of recurrent variceal hemorrhage. A randomized, controlled trial. Ann Intern Med. 126:1997;849-857.
26. Jalan R, Forrest EH, Stanley AJ, Redhead DN, Forbes J, Dillon JF, et al. A randomized trial comparing transjugular intrahepatic portosystemic stent-shunt with variceal band ligation in the prevention of rebleeding from esophageal varices. Hepatology. 26:1997;1115-1122.
27. Cowan DH. Thrombokinetic studies in alcohol related thrombocytopenia. J Lab Clin Med. 81:1973;64-76.
28. Eichner ER, Hillman RS. Effect of alcohol on serum folate level. J Clin Invest. 52:1973;584-591.
29. Paramo JA, Rocha E. Hemostasis in advanced liver disease. Semin Thromb Hemost. 19:1993;184-190.
30. De Noronha R, Taylor BA, Wild G, Triger DR, Greaves M. Interrelationships between platelet count, platelet IgG, serum IgG, immune complexes and severity of liver disease. Clin Lab Hematol. 13:1991;127-135.
31. Peck-Radosavljevic M, Zacherl J, Meng YG, Pidlich J, Lipinski E, Längle F, et al. Is inadequate thrombopoietin production a major cause for thrombocytopenia in cirrhosis of the liver? J Hepatol. 27:1997;127-131.